Neoplasia/BPH

	Persistent lymph node uptake on [18Â F]-FDG PET-CT after neoadjuvant chemotherapy: a major predictive factor of disease-free survival in MIBC. World J Urol Pattou M, Robert G, Gouhizoun O, Guéna F, Khaddad A, Mebroukine S, Margue G, Gross-Goupil M, Lefort F, Morgat C, Bernhard JC, Bladou F, Klein C. PMID: 41493567 [PubMed - indexed for MEDLINE]
	A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol Hudson A, Jayaram A, Garmezy B, Zorko NA, Zarrabi KK, Mathews L, Rupnow B, Li M, Ghosh D, Urtishak K, Francis P, Wang SC, Attiyeh E, de Bono J. PMID: 41493473 [PubMed - indexed for MEDLINE]
	Comments on "Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial". Int J Cancer Dai J, Zhou X. PMID: 41493148 [PubMed - as supplied by publisher]
	Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer. J Comp Eff Res Shore N, Morgans AK, Paracha N, Thom H, Keeney E, Orishaba P, Phillippo D, Aceituno D, Wallis CJ, Gallagher E, Boegemann M. PMID: 41492975 [PubMed - as supplied by publisher]
	Epidemiological trends and future projections of bladder and kidney cancer burden in China, 1990-2041: an ecological study. Chin Clin Oncol Yuan J, Yu S, Zheng J. PMID: 41492875 [PubMed - indexed for MEDLINE]
	Gleason score discrepancies between prostate biopsy and radical prostatectomy in prostate cancer patients: a retrospective single-center analysis. Chin Clin Oncol Chen Y, Luo J, Dong Q, Zhou T, Wang C, Xiao J. PMID: 41492874 [PubMed - indexed for MEDLINE]
	Analysis of Urinary Continence, Complications, and Urodynamic Characteristics Following Orthotopic Ileocaecal Neobladder Reconstruction: A Preliminary Study on Safety and Feasibility. Arch Esp Urol Fu Q, Yan F, Sun Z, Yao Z, Zhang G. PMID: 41492682 [PubMed - indexed for MEDLINE]
	Value Analysis of Operating Room Care Protocol Based on Enhanced Recovery after Surgery (ERAS) Concept in Patients with Prostate Cancer Undergoing Laparoscopic Radical Prostatectomy: A Retrospective Study. Arch Esp Urol Zhang L, Gu C. PMID: 41492681 [PubMed - indexed for MEDLINE]
	Study on Symptom Management Theory-Based Nursing Treatment Model for Patients Undergoing Radical Prostatectomy: A Single-Center, Retrospective Experience. Arch Esp Urol Xu H, Zhong G, He R. PMID: 41492680 [PubMed - indexed for MEDLINE]
	Extraperitoneal Laparoscopic Surgery versus Transurethral Resection for Benign Prostatic Hyperplasia: A Retrospective Comparative Analysis of Perioperative Outcomes and Functional Recovery. Arch Esp Urol Ying X, Gao K, Xu Z, Zhang H, Shen C, Ren Y, Luo Z, Wu G. PMID: 41492677 [PubMed - indexed for MEDLINE]
	Application Value of Prostate-Specific Magnetic Resonance Imaging Features Combined with Nonspecific Serum Markers in Risk Stratification of Clinically Significant Prostate Cancer. Arch Esp Urol Peng Q, Di Q, Wu X, Yang B, Yang H. PMID: 41492675 [PubMed - indexed for MEDLINE]
	High-Intensity Focused Ultrasound for Grade Group 1-3 Localized Prostate Cancer: Oncologic and Safety Outcomes in a Taiwanese Cohort. Arch Esp Urol Li CT, Chen TM, Chang CH. PMID: 41492671 [PubMed - indexed for MEDLINE]
	Bleeding Risks in Urologic Surgery: A Prospective Analysis of Anticoagulant and Antiaggregant Use in Transurethral Resection of Prostate, Transurethral Resection of Bladder Tumour and Open Prostatectomy. Arch Esp Urol Ilktac A, Ersoz C, Kalkan S, Dogan B, Akbulut H, Akcay M, Gevher F, Ilbey YO. PMID: 41492670 [PubMed - indexed for MEDLINE]
	Predictive Value of Serum Biomarkers in Prostate Cancer Progression. Arch Esp Urol Albaz AC, Kosova F, Temelta, Üçer O, Müezzino. PMID: 41492669 [PubMed - indexed for MEDLINE]
	The Usefulness of Martini's Nomogram and the Evaluation of Trifecta and Pentafecta Criteria in Renal Cancer: A Comparison of Open and Robot-Assisted Partial Nephrectomy. Arch Esp Urol Çitgez S, Gültekin MH, , Demirbilek M, Kalender G, Ercili B, Okur A, Demirda, Önal B. PMID: 41492667 [PubMed - indexed for MEDLINE]
	Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer. Genes Dis Li X, Shen Y, Zhang N, Lu D, Ding S, Wu F, Song X, Zhou X, Lin S, Xu H, Wang Z, Yuan F. PMID: 41492471 [PubMed]
	Prospective controlled study comparing patient-reported outcomes after daily online adaptive radiotherapy or conventional IGRT in patients with prostate cancer. Clin Transl Radiat Oncol Kalinauskaite G, Künzel LA, Rubarth K, Nguyen T, Dannehl J, Höhne C, Beck M, Bauer J, Zips D, Senger C. PMID: 41492405 [PubMed]
	Nested Case-Control Study of Incident Prostate Cancer in Danish Male Military Pilots. Am J Ind Med Pedersen JE, Hansen J. PMID: 41492183 [PubMed - as supplied by publisher]
	The role of ferroptosis in renal cell carcinoma: molecular mechanisms and therapeutic implications. J Mol Med (Berl) Wang Z, Kong D, Wei W. PMID: 41491742 [PubMed - indexed for MEDLINE]
	Multiphase CT-Based Tumor and Peritumoral Radiomics for Characterization of Clear Cell Renal Cell Carcinoma. J Imaging Inform Med Muellner M, Pawan SJ, Lei X, Aron M, Desai M, Gurram N, Garg M, Cen SY, Duddalwar V. PMID: 41491739 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184443

Page 1 of 9223



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy